Relevant bibliographies by topics / Hepatitis treatment

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Hepatitis treatment'

Author: Grafiati
Published: 7 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatitis treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatitis treatment"

1

Djuraev, Jamolbek A., Shokhimardon Kh Khodjanov, Azizkhon Z. Shaumarov, et al. "MODERN METHODS OF TREATMENT OF VIRAL HEPATITIS." International Journal of Medical Sciences And Clinical Research 03, no. 02 (2023): 69–75. http://dx.doi.org/10.37547/ijmscr/volume03issue02-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fazylov, V. Kh. "Etiological and pathogenetic aspects of diagnosis and treatment of viral hepatitides." Kazan medical journal 94, no. 6 (2013): 785–92. http://dx.doi.org/10.17816/kmj1791.

Full text
Abstract:
The commencement address highlights the results of the long-term scientific research of the department of infectious diseases of the Kazan State Medical University on the problems of viral hepatitides diagnosis, treatment and prevention. The era of research of the acute viral hepatitides was based primarily on the clinical and biochemical differential diagnosis, considering epidemiologic data and specific prevention (vaccination) of hepatitis A and B. The development of modern technologies opened up new opportunities for etiologic decoding and morphologic evaluation of the infectious process a
APA, Harvard, Vancouver, ISO, and other styles
3

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Full text
Abstract:
Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was
APA, Harvard, Vancouver, ISO, and other styles
4

Bock, Kirsten, Andrea Atkinson, Chelsea Elwood, and Alnoor Ramji. "Case report of Hepatitis C treatment during pregnancy." Journal of Case Reports and Images in Obstetrics and Gynecology 14, no. 2 (2023): 39–42. http://dx.doi.org/10.5348/100162z08kb2023cr.

Full text
Abstract:
Introduction: Despite the increasing availability of Hepatitis C (HCV) anti-viral therapy for adults, there is minimal data regarding treatment safety and efficacy during pregnancy. Case Report: A 33-year-old primiparous female underwent successful HCV treatment with direct-acting antivirals (DAAs) beginning at 26 weeks gestational age. Conclusion: This case demonstrates the effective treatment of HCV during pregnancy. Formal trials are still required to assess the long-term safety and efficacy as treatment with DAAs for Hepatitis C is not yet established in pregnancy.
APA, Harvard, Vancouver, ISO, and other styles
5

Downey, Nancy H. "Hepatitis C Treatment." Gastroenterology Nursing 31, no. 2 (2008): 162. http://dx.doi.org/10.1097/01.sga.0000316567.85555.71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mayhew, Maren S. "Hepatitis C Treatment." Journal for Nurse Practitioners 7, no. 10 (2011): 875–76. http://dx.doi.org/10.1016/j.nurpra.2011.09.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Brook, M. G. "Treatment of hepatitis." Journal of Hospital Infection 11 (February 1988): 175–81. http://dx.doi.org/10.1016/0195-6701(88)90184-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Blatt, Carine Raquel, Bernd Storb, Nikolai Mühlberger, Mareni Rocha Farias, and Uwe Siebert. "Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment." Brazilian Journal of Pharmaceutical Sciences 50, no. 2 (2014): 345–52. https://doi.org/10.1590/S1984-82502014000200014.

Full text
Abstract:
Brazilian Guidelines to HCV treatment (2007) recommended that the first choice treatment for patients with chronic hepatitis C (CHC) and genotype 2 or 3 is interferon alpha (IFN) plus ribavirin (RBV) for 24 weeks. The aim of this study is compare the cost and effectiveness to Hepatitis C treatment in patients with genotype 2 or 3 of peginterferon alpha (PEG) as the first choice of treatment within PEG for those that do not respond to IFN. The target population is CHC patients with genotype 2 or 3 in Brazil. The interventions are: PEG-SEC (first IFN plus RBV for 24 weeks, after, for non-respond
APA, Harvard, Vancouver, ISO, and other styles
9

Ukashah, Muhamma. "Different Tools Used for Treatment of Chronic Hepatitis B." Open Access Journal of Endocrinology 6, no. 1 (2022): 1–5. http://dx.doi.org/10.23880/oaje-16000176.

Full text
Abstract:
Currently different vaccines are available for cure and medicines are also available since 1988 but still 250 million people are infected with hepatitis B virus. The viruses of hepatitis B and hepatitis C causes liver cancer and also tuberculosis and malaria. The well developed and under developing countries both are very poor in care that can reduce the risk of hepatitis B. If we talk about United States only one third of those people who are infected with this virus are aware of their infection. The main reason for this un awareness is that the asymptomatic nature of hepatitis B virus as the
APA, Harvard, Vancouver, ISO, and other styles
10

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Full text
Abstract:
Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatitis treatment"

1

Williams, Stephen John. "Chronic hepatitis B virus infection : prevention and treatment." Thesis, The University of Sydney, 1989. https://hdl.handle.net/2123/26390.

Full text
Abstract:
Hepatitis B virus (HBV) infection is an increasing public health problem in Australia particularly in certain 'high-risk' subgroups of the population. In order to establish cost-effective screening and vaccination programs directed towards the control and possible eradication of HBV infection, accurate information is needed about the modes of spread and the numbers of "at risk" individuals in particular community subgroups. In addition, treatment strategies must be developed for established HBV carriers since at least 35% of such individuals will die directly related to complications of the di
APA, Harvard, Vancouver, ISO, and other styles
2

Carlsson, Tony. "Hepatitis C virus kinetics during antiviral treatment /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-588-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bangera, Sudhakar Sheena. "Review of hepatitis B treatment : in practice and in development /." Thesis, Hong Kong : University of Hong Kong, 2001. http://sunzi.lib.hku.hk/hkuto/record.jsp?B24873147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sangfelt, Per. "Prevention and treatment of hepatitis B virus infection /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-301-9/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Watson, Henry G. "Viral hepatitis as a complication of haemophilia treatment." Thesis, University of Aberdeen, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337399.

Full text
Abstract:
Post transfusion hepatitis is seen in all haemophiliacs treated with non-virus inactivated (NVI) concentrates. First generation anti-HCV ELISA produced false negative results in 10/78, with four individuals ELISA negative, HCV RNA positive. Using second generation assays incorporating c22, C1-4 and c33c peptides, HCV infection was demonstrated in all recipients of NVI concentrates and 0/7 PUPS treated with heat treated concentrates. Phylogenetic analysis of HCV sequences outlined the demographic of HCV infection in Edinburgh and suggested that recent post-transfusion HCV infection is due to tr
APA, Harvard, Vancouver, ISO, and other styles
6

Seto, Wai-kay Walter, and 司徒偉基. "Virologic and serologic kinetics in the natural history and treatment of chronic hepatitis B." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48671071.

Full text
Abstract:
This thesis investigated how virologic and serologic kinetics of the hepatitis B virus (HBV) could influence the natural history and treatment of chronic hepatitis B (CHB). Virologic kinetics were described in the first five studies, with serologic kinetics being described in the next five. The first study delineated the HBV DNA profiles of 1,400 treatment-naive Asian CHB patients. Increasing viremia was noted with increasing age, highlighting the large therapeutic demand in Asian patients with hepatitis B e antigen (HBeAg)-negative CHB. The second study analyzed the association between vira
APA, Harvard, Vancouver, ISO, and other styles
7

Weegink, Christine Joanne. "Hepatitis C infection the quest for new treatment strategies /." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2004. http://dare.uva.nl/document/74129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lewis, Heather Ilona. "Improving ascertainment and treatment rates of chronic viral hepatitis." Thesis, Queen Mary, University of London, 2017. http://qmro.qmul.ac.uk/xmlui/handle/123456789/30632.

Full text
Abstract:
Introduction and aims: In the United Kingdom hepatitis B virus (HBV) and hepatitis C virus (HCV) disproportionately affect migrants and people who inject drugs (PWID). Ascertainment rates of HBV and HCV are 10-40% and screening is recommended in at risk groups. Treatment uptake for HCV in PWID is low at 2-18%, and the most effective way to increase uptake is not known. This research aims to evaluate methods to address the low ascertainment and treatment rates of HBV and HCV in these populations. Methods: A pilot observational cohort study of screening for chronic viral hepatitis in primary car
APA, Harvard, Vancouver, ISO, and other styles
9

Yuen, King-tai, and 袁敬弟. "A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193555.

Full text
Abstract:
The cost effectiveness of using novel HCV treatment option, telaprevir and boceprevir, should depend on patients’ respond to conventional PEG-INFα and ribavirin therapy. The study of pharmacogenomics, interleukin-28B (IL-28B) polymorphisms, accompanied with the information of HCV genotypes are suggested to have the strongest predictive value of treatment outcomes and prognosis of disease in individuals infected with HCV who are undergoing conventional PEG-INFα and ribavirin therapy. It is extremely valuable in HCV/HIV co-infected patients as these groups of patients require a complex treatment
APA, Harvard, Vancouver, ISO, and other styles
10

Christou, Marie-Grace. "Conditionally activated therapeutics for the treatment of hepatitis C." Thesis, University of Ottawa (Canada), 2004. http://hdl.handle.net/10393/26609.

Full text
Abstract:
Hepatitis C virus (HCV) is the etiologic agent responsible for the majority of cases of non-A, non-B hepatitis. It is estimated that 2% of the world's population is infected with hepatitis C with roughly 75% of infections progressing into a chronic state. Current interferon therapy is largely ineffective against chronic Hepatitis C due to the induction of interferon-resistance by HCV. The underlying mechanisms for resistance to interferon therapy have been widely studied and documented and as is the case in interferon resistant malignancies, there is some evidence that HCV infected cells are m
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hepatitis treatment"

1

Colacino, Joseph M., and Beverly A. Heinz, eds. Hepatitis Prevention and Treatment. Birkhäuser Basel, 2004. http://dx.doi.org/10.1007/978-3-0348-7903-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chayama, Kazuaki, ed. Hepatitis C Virus Treatment. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2416-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

1936-, Willson Richard A., ed. Viral hepatitis: Diagnosis, treatment, prevention. M. Dekker, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hatzakis, Angelos, ed. Hepatitis C: Care and Treatment. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67762-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dinsdale, R. C. W. Viral hepatitis, AIDS and dental treatment. British Dental Journal, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Colbert, Don. The Bible cure for hepatitis and hepatitis C. Siloam Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Oyakhire, Peter I. Healing hepatitis & liver disease naturally: A holistic guide to living with hepatitis and liver disease. Authorhouse, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. T. Duncan, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Beck, Allen J. Hepatitis testing and treatment in state prisons. U.S. Dept. of Labor, Office of Justice Programs, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Texas. Dept. of Health. Hepatitis C action plan for Texas. Texas Dept. of Health, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hepatitis treatment"

1

Kwon, Hellan K., and Anna S. F. Lok. "Treatment of Hepatitis B." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Welsch, Christoph, and Stefan Zeuzem. "Treatment of Hepatitis C." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ciancio, Alessia, and Mario Rizzetto. "Treatment of Hepatitis D." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cannon, Mary D., Kosh Agarwal, and Geoffrey Dusheiko. "Hepatitis C: Treatment." In Evidence-based Gastroenterology and Hepatology 4e. John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781119211419.ch31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Damen, M., and D. Bresters. "Hepatitis C Treatment." In Current Studies in Hematology and Blood Transfusion. KARGER, 1998. http://dx.doi.org/10.1159/000060479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Demirel, Aslıhan, and Resat Ozaras. "Future Drugs in the Treatment of HBV." In Viral Hepatitis: Chronic Hepatitis B. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-93449-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kurstak, Edouard. "Treatment of hepatitis B virus disease." In Viral Hepatitis. Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-4437-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kurstak, Edouard. "Hepatitis D: epidemiology, prevention and treatment." In Viral Hepatitis. Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-4437-4_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Blatt, Lawrence M., and Myron Tong. "Epidemiology of chronic hepatitis viruses: hepatitis B virus and hepatitis C virus." In Hepatitis Prevention and Treatment. Birkhäuser Basel, 2004. http://dx.doi.org/10.1007/978-3-0348-7903-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Levy, Cynthia. "Treatment Side Effects and Associated Autoimmune Diseases." In Autoimmune Hepatitis. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-60761-569-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hepatitis treatment"

1

Meena, Jaishree, Avdhesh Gupta, Rashmi Sharma, Vishan Kumar Gupta, Harvinder Singh, and Vanshika Sachdeva. "Artificial Intelligence Transforming Hepatitis Diagnosis, Treatment, and its Research Frontiers." In 2025 4th OPJU International Technology Conference (OTCON) on Smart Computing for Innovation and Advancement in Industry 5.0. IEEE, 2025. https://doi.org/10.1109/otcon65728.2025.11070342.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ekmen, Onder. "A Case of Fulminant Hepatitis B Reactivation After Hepatitis C Treatment in Hepatitis B+C Co-infection." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Brito, A., A. Fernandes, L. Lourenço, S. Domingos, A. Soares, and A. Alcobia. "1ISG-006 Hepatitis C treatment: cost and effectiveness." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zandanell, S., L. Balcar, G. Semmler, et al. "Genetic Variants Determine Treatment Response in Autoimmune Hepatitis." In 56. Jahrestagung & 33. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH & ˶Pre˵ Symposium der young ÖGGH. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1769061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cabo, Domingos Jose Vaz Do, Silvia Helena Grosso Esher, Maria Filomena Xavier Mendes, Romeu Carillo Jr, and Maria Solange Gosik. "Developing Homeopathic Treatment Guidelines for Patients with Hepatitis C." In HRI London 2019—Cutting Edge Research in Homeopathy: Presentation Abstracts. The Faculty of Homeopathy, 2020. http://dx.doi.org/10.1055/s-0040-1702136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Centeno, B. Lopez, V. Alonso Castro, A. Gil Martín, I. Martín Casasempere, A. Aranguren Oyarzábal, and MJCalvo Alcántara. "4CPS-217 Hepatitis b treatment: towards effectiveness and adherence." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.307.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lima, Laís Cruz, Maurício Prätzel Ellwanger, Manuela Pozza Ellwanger, et al. "CLINICAL AND EPIDEMIOLOGICAL PROFILE OF HEPATITIS B AND C PATIENTS IN A MUNICIPALITY IN SOUTHERN BRAZIL." In I Congresso Internacional Multidisciplinar de Ciências da Saúde - I CIMS. New Science Publishers, 2024. http://dx.doi.org/10.56238/i-cims-012.

Full text
Abstract:
Context: Hepatitis B and C are common diseases with significant public health impacts. Hepatitis B is primarily transmitted through sexual contact, classifying it as a sexually transmitted infection, while hepatitis C is mainly transmitted through blood. Without early and proper treatment, these infections can lead to complications such as hepatocellular carcinoma and liver cirrhosis. Objective: To determine the clinical-epidemiological profile of hepatitis B and C patients treated at a specialized health center in a municipality in southern Santa Catarina from 2016 to 2020. Methods: A retrosp
APA, Harvard, Vancouver, ISO, and other styles
8

Guo, Chenkai, and Jingyu Luo. "Hepatitis B virus infection: Overview and new treatment targeting NTCP." In 4TH INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0094816.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Martinez, E., S. Corrales, C. Dean, et al. "5PSQ-033 Antiviral treatment discontinuation in patients with hepatitis b." In 27th EAHP Congress, Lisbon, Portugal, 22-23-24 March 2023. British Medical Journal Publishing Group, 2023. http://dx.doi.org/10.1136/ejhpharm-2023-eahp.255.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schwambach, Karin Hepp, and Carine Raquel Blatt. "Effectiveness and costs: real-world data to Hepatitis C treatment." In PRIMEIRO CONGRESSO DA REBRATS. Galoa, 2019. http://dx.doi.org/10.17648/rebrats-2019-113738.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hepatitis treatment"

1

Kuypers, Marshall A., Gregory Joseph Lambert, Thomas W. Moore, et al. Modeling Hepatitis C treatment policy. Office of Scientific and Technical Information (OSTI), 2013. http://dx.doi.org/10.2172/1096266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lyons, Megan, Thomas Bennett, Felicia Gray-Hamilton, and Margaret Harvey. Hepatitis C Virus Screening Strategies to Improve Early Identification and Treatment: ​ A Scoping Review​. University of Tennessee Health Science Center, 2023. http://dx.doi.org/10.21007/con.dnp.2023.0046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Holtzmuller, Kent. Utilization of Telemedicine for Evaluation and Treatment of Hepatitis C Patients in Military Health Clinics. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada396498.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Holtzmuller, Kent. Utilization of Telemedicine for Evaluation and Treatment of Hepatitis C Patients in Military Health Clinics. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392494.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Goller, Jane, Stephanie Munari, Cassandra Caddy, et al. General Practice engagement: STI, HIV and viral hepatitis care. The Sax Institute, 2023. http://dx.doi.org/10.57022/lnur4773.

Full text
Abstract:
Early detection and treatment of sexually transmitted infections, HIV, and hepatitis B and C are vital to minimise the harm they cause. This Evidence Check aimed to identify effective initiatives that engage and support GPs and the GP clinic workforce in NSW to increase testing for these conditions. It also aimed to identify effective modifications to practice management software to increase GP engagement in screening and care for these conditions. Sixty-two articles were found in total. The most effective initiatives used multiple interventions, particularly provider education and quality imp
APA, Harvard, Vancouver, ISO, and other styles
6

Zeng, Hua, and Yuanliang Liu. Entecavir in the treatment of chronic hepatitis B in children and adolescents:Systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Evon, Donna, Jipcy Amador, Paul Stewart, et al. Changes in Health for Patients Who Complete Treatment for Chronic Hepatitis C Virus -- The PROP up TARGET Study. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/06.2020.cer.140820660.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mark, Tami L., William N. Dowd, and Carol L. Council. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality. RTI Press, 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0040.2007.

Full text
Abstract:
The objective of this study was to track trends in the signs of higher-quality addiction treatment as defined by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Addiction, and the Substance Abuse and Mental Health Services Administration. We analyzed the National Survey of Substance Abuse Treatment Services from 2007 through 2017 to determine the percent of facilities having the characteristics of higher quality. We analyzed the percent by state and over time. • We found improvements between 2007 and 2017 on most measures, but performance on several measures r
APA, Harvard, Vancouver, ISO, and other styles
9

Anwar, Muhammad Tayyab, Muhammad Shahzil, Taha Bin Arif, et al. Efficacy and Safety of Mycophenolate Mofetil (MMF) vs Azathioprine (AZA) for Treatment Naive Autoimmune Hepatitis: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.1.0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zhu, Baoqiang, Xue Tao, Yuankui Wei, et al. The efficacy and safety of oral hepatoprotective agents combined with entecavir in the treatment of chronic hepatitis B: a network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.11.0024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hepatitis treatment' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography